相关实验视频

Updated: Jul 8, 2026

Graphene Coatings for Biomedical Implants

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

石墨烯功能化碳化物合成和表征及其对癌症细胞系的细胞毒性影响

Devanshi C¹, Geetha A¹, Ilangovar Igk¹

¹Department of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, IND.

|June 25, 2024

概括

这项研究合成了石墨烯功能化碳化物,证明了对癌症细胞系的显著抗癌活性. 这种新的材料对未来的癌症治疗和生物医学应用具有前景.

科学领域:

材料科学材料科学材料科学
纳米技术纳米技术
生物医学工程生物医学工程

背景情况:

石墨烯和MXene是具有特殊性能的2D材料,用于电子,能源和生物医学.
作为一种过渡金属碳化物/化物,MXene具有强烈的水亲和力和电导性.
石墨烯的独特特性使其在生物和医学应用中具有价值.

研究的目的:

合成和表征石墨烯功能化的MXene (特别是石墨烯功能化的碳化).
为了研究合成材料对癌细胞系的细胞毒性作用.
评估石墨烯功能化碳化物作为抗癌剂的潜力.

主要方法:

石墨烯溶液通过研磨和超声波处理制备.
从碳化和酸中合成的MXene.
石墨烯和MXene相结合,经过热水处理,经过净化和干燥.
使用SEM,XRD和FTIR进行表征;通过MTT试验评估细胞毒性.

主要成果:

通过XRD,SEM和FTIR证实了石墨烯功能化碳化的成功合成和表征.
XRD揭示了一个高度结晶的结构,具有明显的层次堆叠.
合成材料对癌症细胞系产生显著的细胞毒性作用,表明抗癌活性和改善生物相容性.

结论:

用石墨烯功能化碳化物成功合成和特征化.
该物质对癌细胞系表现出显著的细胞毒性作用,突出了其作为抗癌剂的潜力.
进一步的跨学科研究对于临床转化和癌症治疗中的应用至关重要.

关键词:

癌细胞癌细胞癌细胞细胞毒性作用细胞毒性作用石墨烯是一种石墨烯.这是一个MTT测试.mxenexene 在线观看没有,没有,没有,没有.第十三天的第十一天.

更多相关视频

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...